Pharmelle SRL
Pharmelle reported total assets of 48,646 € at the end of the 2025 financial year (annual accounts filed with the NBB on 07 Jul 2026).
The score of Pharmelle shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -22 % Total assets +191 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmelle's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 02 Jul 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 14 Jun 2023
- Year ended 31 Dec 2021filed on 20 Jun 2022
Pharmelle's financial analysis
- Solvency21.4%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmelle
Pharmelle's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0760.602.338
- VAT number
- BE0760602338
- Peppol
- Registered · 0208:0760602338 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Dec 2020
- Registered office
- 9300 Aalst
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmelle (SRL) has been based in Aalst since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 7,408 € and equity of 10,408 €; its revenue is not published. Its solvency stands at 21.4%, below the median of its sector (44.2%).
Companies similar to Pharmelle
Companies in the same business, of comparable size and area, outside its group.
- Zyntra Advisory Research and experimental development on natural sciences and engineering Etterbeek · balance sheet 22,045 €
- Pharmacie DES Pagodes Manufacture of basic pharmaceutical products Genappe · balance sheet 383,064 €
- Bioxtract Research and experimental development on natural sciences and engineering Somme-Leuze · balance sheet €1.09m
- ELI Retail sale of pharmaceutical products Genk · balance sheet 53,448 €
- Lotte Deroover Retail sale of pharmaceutical products Boortmeerbeek · balance sheet 39,701 €
- Apotheker Laura Spiritus Retail sale of pharmaceutical products Linter · balance sheet 62,639 €
- Manon De Marez Retail sale of pharmaceutical products Herent · balance sheet 85,130 €
- FarmaST Retail sale of pharmaceutical products Zonhoven · balance sheet 107,177 €
Frequently asked questions about Pharmelle
What is the revenue of Pharmelle?
Pharmelle files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmelle?
In Belgium, the VAT number is the company number prefixed with BE: BE0760602338 for Pharmelle, if the company is VAT-registered. Its company number (CBE) is 0760.602.338.
Where is the registered office of Pharmelle?
According to the CBE register, the registered office of Pharmelle is in 9300 Aalst.
What is the equity of Pharmelle?
At the close of the 2025 financial year, the equity of Pharmelle amounts to 10,408 €, a solvency of 21.4% of total assets.
Who manages Pharmelle?
The register lists 1 active mandates at Pharmelle. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmelle
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →